Blueprint Medicines Corporation focuses on Ayvakit, BLU-808, and Elenestinib with strong potential in mast cell disorders.

Malta with EU’s lowest cancer mortality rate • Lower incidence of cancer among men • Concern on cost of cancer medicines and ...

Secondary Lymphedema is much more common. It is caused by damage to the lymphatic system from surgery, radiation therapy, infection, or trauma. It affects 1 in 1000 Americans, so there are 350,000 US ...

Target enrollment achieved in RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, strengthening confidence in clinical timelinesEnrollment underway in ...

Oncolytic adenovirus was engineered for the forced ectopic delivery of peptide-MHC ligand of T cell receptors (TCRs) to ...

The folks over at buzzy Chinese AI lab, DeepSeek, are working on a new series of AI models called DeepSeek-GRM that employ a ...

FemiPro emerges at a pivotal moment in women's health. Millions of women quietly endure urinary incontinence - from frequent ...

Infectious diseases are becoming more frequent, more severe, and harder to control in our closely connected world. Viruses ...